Moorfields Eye Hospital

London UK EC1V 2PD

5 studies enrolling now · 52 studies all time

What they study most

Acanthamoeba Keratitis, Age-Related Macular Degeneration, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Chorioretinal Degeneration, Choroideremia, Deaf Blind, Diabetic Macular Edema, Diabetic Retinopathy, Dry Age-related Macular Degeneration, Exudative Age-Related Macular Degeneration, Eye Diseases

Studies at this site

• A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema — Recruiting now
• Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants — Recruiting now
• Parasitic Ulcer Treatment Trial — Recruiting now
• EyeConic: Qualification for Cone-Optogenetics — Recruiting now
• A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy — Running, not enrolling
• Rate of Progression in USH2A-related Retinal Degeneration — Running, not enrolling
• A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP) — Running, not enrolling
• Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene — Running, not enrolling
• Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa — Completed
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) — Completed
• A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP — Running, not enrolling
• A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease. — Stopped early
• Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene — Completed
• A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — Completed
• Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F — Running, not enrolling
• FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD — Stopped early
• Gyrate Atrophy Ocular and Systemic Study — Running, not enrolling
• Long-term Follow-up Gene Therapy Study for RPGR- XLRP — Completed
• Study of Serine Supplementation to Protect Vision in MacTel — Starting soon
• Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study — Running, not enrolling
• Non-proliferative Diabetic Retinopathy Treated With Runcaciguat — Completed
• Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease — Completed
• NA-AION Risk Factors: New Perspectives — Completed
• A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment — Completed
• A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD) — Completed
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) — Stopped early
• Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) — Stopped early
• Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR) — Completed
• HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia — Completed
• PRESERFLO® MicroShunt Extension Study — Completed
• Serine and Fenofibrate Study in Patients With MacTel Type 2 — Running, not enrolling
• A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy — Stopped early
• Natural History Study of Patients With Leber Congenital Amaurosis Associated With Mutations in RPE65 — Completed
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial — Completed
• Study to Assess the Efficacy and Safety of Raxone in LHON Patients — Completed
• InnFocus MicroShunt Versus Trabeculectomy Study — Completed
• Primary Tube Versus Trabeculectomy Study — Completed
• A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. — Completed
• A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD) — Completed
• Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert — Completed
• Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration — Completed
• A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies — Completed
• A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration — Stopped early
• PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial — Completed
• The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy — Completed
• A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension — Completed
• Tube Versus Trabeculectomy (TVT) Study — Completed
• Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial. — Completed
• Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion — Completed